Skip to main content
AbbVieFacility expansion

AbbVie expands Oxford R&D facility as part of £120 million-plus investment

Source: Autobound Signal API · 112 signals tracked for AbbVie · updated

Get AbbVie's live signals in Claude or ChatGPT, or by API

AskWhat changed at AbbVie this week? Use Autobound signals for abbvie.com.

What happened

AbbVie expanded its UK research and development facility in Oxford as part of an investment of more than £120 million.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Bengaluru: AbbVie has expanded its UK research and development facility in Oxford as part of a more than £120 million ($161 million) investment, the US drugmaker said on Wednesday. The investment comes a few months after the US and Britain finalised an agreement aimed at increasing UK medicine prices in line with President Donald Trump's new US pricing policies. Advt The new 12,000-square-foot site, known as AbbVie Oxford, will broaden its research capabilities across immunology, neuroscience and oncology The facility builds on capabilities gained through the 2022 acquisition of Oxford-based biotechnology company DJS Antibodies The investment will support research focused on identifying new disease targets and combination therapies in areas with significant unmet medical need Event Biotech Leadership Symposium 2026 India's biotech industry, has largely been driven by vaccines, biosimilars and contract manufacturing. The country already supplies over 60 per cent of global vaccines, reinforcing its reputation as a global manufacturing powerhouse. However, the next decade will be defined by more complex scientific challenges: vaccines for emerging pathogens, therapies for rare diseases affecting an estimated 70 to 96 million Indians, and solutions to antimicrobial resistance (AMR), which contributes to over 1 million deaths annually in India. As Indian companies begin investing...

Keep reading with a free account

The rest of this article, and every signal for AbbVie, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Facility expansion

What this signalsA bigger facility often needs new equipment, systems and services.

Takes effect
Nov 4, 2026
Location
Oxford, England, United Kingdom

More facility expansion signals at other companies

The full record

From the Signal API record

Extraction

Confidence
95%
Detected
Nov 4, 2026
signal_type
news
signal_subtype
expands_facilities

Use this data

Get every facility expansion signal for AbbVie and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”

  2. Send it to your own tools

    The Signal API returns facility expansion signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/c72d826c-bf20-0dbf-a692-43f7c996d611 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.

{
  "signal_id": "c72d826c-bf20-0dbf-a692-43f7c996d611",
  "signal_type": "news",
  "signal_subtype": "expands_facilities",
  "detected_at": "2026-11-04T06:44:29+00:00",
  "company": {
    "name": "AbbVie",
    "domain": "abbvie.com"
  },
  "data": {
    "url": "https://pharma.economictimes.indiatimes.com/amp/news/pharma-industry/abbvie-expands-oxford-rd-facility-as-part-of-120-million-plus-investment/135527988",
    "title": "AbbVie expands Oxford R&D facility as part of £120 million-plus investment - pharma.economictimes.indiatimes.com",
    "excerpt": "Bengaluru: AbbVie has expanded its UK research and development facility in Oxford as part of a more than £120 million ($161 million) investment, the US drugmaker said on Wednesday. The investment comes a few months after the US and Britain finalised an agreement aimed at increasing UK medicine prices in line with President Donald Trump's new US pricing policies. Advt The new 12,000-square-foot site, known as AbbVie Oxford, will broaden its research capabilities across immunology, neuroscience and oncology The facility builds on capabilities gained through the 2022 acquisition of Oxford-based biotechnology company DJS Antibodies The investment will support research focused on identifying new disease targets and combination therapies in areas with significant unmet medical need Event Biotech Leadership Symposium 2026 India’s biotech industry, has largely been driven by vaccines, biosimilars and contract manufacturing. The country already supplies over 60 per cent of global vaccines, reinforcing its reputation as a global manufacturing powerhouse. However, the next decade will be defined by more complex scientific challenges: vaccines for emerging pathogens, therapies for rare diseases affecting an estimated 70 to 96 million Indians, and solutions to antimicrobial resistance (AMR), which contributes to over 1 million deaths annually in India. As Indian companies begin investing...",
    "summary": "AbbVie expanded its UK research and development facility in Oxford as part of an investment of more than £120 million.",
    "location": "Oxford, England, United Kingdom",
    "planning": false,
    "image_url": "https://etimg.etb2bimg.com/thumb/msid-135527988,imgsize-2311147,width-1200,height=627,overlay-etpharma,resizemode-75/news/pharma-industry/abbvie-expands-oxford-rd-facility-as-part-of-120-million-plus-investment.jpg",
    "confidence": 0.95,
    "published_at": "2026-11-04T06:44:29Z",
    "location_data": [
      {
        "city": "Oxford",
        "state": "England",
        "region": "Northern Europe",
        "country": "United Kingdom",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-11-04",
    "article_sentence": "AbbVie has expanded its UK research and development facility in Oxford as part of a more than £120 million ($161 million) investment, the US drugmaker said on Wednesday."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.